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Retinal organoids derived from 
hiPSCs of an AIPL1-LCA Patient 
Maintain cytoarchitecture despite 
Reduced levels of Mutant AIPL1
Dunja Lukovic1,2*, Ana Artero castro2, Koray Dogan Kaya3, Daniella Munezero4, 
Linn Gieser3, Carlota Davó-Martínez2, Marta corton5, Nicolás cuenca6, Anand Swaroop  3, 
Visvanathan Ramamurthy4, Carmen Ayuso5 & Slaven erceg2,7
Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) is a photoreceptor-specific chaperone that 
stabilizes the effector enzyme of phototransduction, cGMP phosphodiesterase 6 (PDE6). Mutations 
in the AIPL1 gene cause a severe inherited retinal dystrophy, Leber congenital amaurosis type 4 
(LCA4), that manifests as the loss of vision during the first year of life. In this study, we generated 
three-dimensional (3D) retinal organoids (ROs) from human induced pluripotent stem cells (hiPSCs) 
derived from an LCA4 patient carrying a Cys89Arg mutation in AIPL1. This study aimed to (i) explore 
whether the patient hiPSC-derived ROs recapitulate LCA4 disease phenotype, and (ii) generate a 
clinically relevant resource to investigate the molecular mechanism of disease and safely test novel 
therapies for LCA4 in vitro. We demonstrate reduced levels of the mutant AIPL1 and PDE6 proteins in 
patient organoids, corroborating the findings in animal models; however, patient-derived organoids 
maintained retinal cell cytoarchitecture despite significantly reduced levels of AIPL1.
Hereditary retinal degenerations are clinically and genetically heterogeneous and constitute a major cause of 
incurable visual impairment in working age adults. Unfortunately, this group of diseases currently lacks effective 
treatment options. Among the divergent clinical phenotypes, Leber congenital amaurosis (LCA) accounts for 
∼5% of all inherited retinopathies and is among the most severe, with patients exhibiting visual dysfunction and 
losing electroretinogram signals during the early years of age1. Patients typically present nystagmus (repetitive, 
uncontrolled movements of the eyes), poor pupillary light response, and fundus abnormalities2. Currently, as 
many as 25 genes have been identified as causing LCA (https://sph.uth.edu/retnet/) primarily in an autosomal 
recessive manner; however, genetic defects have not been identified in almost 30% of LCA patients2. All known 
causative genes are expressed in photoreceptors and/or the retinal pigment epithelium (RPE) and associated with 
a wide range of functions, including phototransduction, retinoid cycling, protein trafficking, and ciliary transport.
Mutations in the aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) gene lead to early onset retinal 
disease and account for up to 5–10% of all mutations causing LCA3 resulting in a clinically severe form, LCA type 
4 (LCA4, OMIM #604393)4. The AIPL1 gene locates to chromosome 17, with 79 mutations identified to date as 
causing LCA (Human Genome Mutation Database). AIPL1 encodes a 384 amino acid protein expressed only in 
photoreceptors and the pineal gland5. The protein has an FK506-binding protein (FKBP)-like domain within the 
N terminus, a tetratricopeptide (TPR) domain with three TPR repeats, and a primate unique proline-rich domain 
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at the C-terminus. FKBPs containing TPR domains represent a specific class of immunophilins, a subfamily of 
chaperones with peptidyl-prolyl cis-trans isomerase (PPIase) activity. This activity interconverts isoforms of pro-
line peptide bonds from cis to trans, a rate-limiting step in protein folding. These chaperones typically have roles 
in the transport of protein complexes, translocation, and the formation of receptors and apoptotic complexes6,7. 
However, the active residue required for PPIase activity is absent in AIPL1.
Animal models have provided insights into the role of AIPL1 and revealed normal development but rapid 
degeneration of rods and cones by four weeks after birth in mice8,9. Furthermore, AIPL1 dysfunction associ-
ates with the destabilization of a central player in phototransduction, the phosphodiesterase 6 (PDE6) effector 
enzyme. This holoenzyme, composed of α and β catalytic subunits and two identical inhibitory γ subunits, is the 
primary regulator of light-dependent changes in cyclic guanosine monophosphate (cGMP). PDE6 is an essential 
signaling molecule in the visual transduction cascade, and its absence leads to rapid photoreceptor degeneration 
and vision loss10–13. AIPL1 interacts with PDE6α and is essential for the assembly of the PDE6 heteromeric com-
plex in photoreceptors14,15. In cones, PDE6 membrane association and assembly is impaired which, together with 
reduced levels of guanylate cyclase (RetGC), leads to cGMP reduction and cone cell death9,15. PDE6α can be mod-
ified by a farnesyl lipid group at C-terminal–CAAX box, with this type of prenylation enhancing protein–mem-
brane and protein-protein interactions16,17. The mechanism underlying the chaperone activity of AIPL1 involves 
binding of isoprenyl groups on PDE6α to the FKBP domain of AIPL1. The crystal structure of AIPL1-FKBP 
demonstrated a uniquely specialized lipid binding motif involving a conformational switch of W72 residue18. 
Additionally, AIPL1 may promote the stability of PDE6 via an interaction with HSP90, thus rescuing PDE6 from 
proteasomal degradation19. AIPL1 also interacts with the NUB1 (NEDD8 Ultimate Buster 1) cell cycle progres-
sion control protein by downregulating NEDD8 expression20, thus suggesting that the early onset of disease may 
be a result of the misregulation of photoreceptor development rather than a visual phototransduction defect.
Our current knowledge on AIPL1 derives from animal knockdown and knockout models, and so, we still 
understand little regarding the molecular mechanism of AIPL1 deficiency in the human context. The unique 
nature of human retinal development21 underscores the need to address the role of AIPL1 in human models 
to fully decipher the pathogenicity of AIPL1 mutations and eventually test disease targets and design thera-
pies. The groundbreaking discovery of the Sasai group set the stage for the generation of pluripotent stem cell 
(PSC)-derived three-dimensional (3D) retinal organoids (ROs) that recapitulate major steps of retinogenesis and 
self-organize into stratified neural retina with maturing photoreceptor features22–25. This approach offers a plat-
form for the exploration of early human retinal development in vitro and supports photoreceptor cellular segmen-
tation with nascent light-sensing outer segment (OS) formation within a native retina histoarchitecture that was 
impossible to achieve in classical two-dimensional cultures or cellular overexpression models. Patient-specific 
human induced (hi)PSC-derived ROs have also been employed to model retinal diseases, including LCA26–28.
In this study, we developed a model of LCA4 by harnessing the potential of patient-specific hiPSCs to recapitu-
late human retinogenesis in a 3D culture system and interrogated the molecular and cellular events in the absence 
of functional AIPL1. We used hiPSCs from a patient clinically diagnosed with LCA and molecularly genotyped 
to harbor a Cys89Arg mutation in AIPL129 that has been proposed to disrupt the farnesyl/FKBP interaction30. 
We induced AIPL1-LCA hiPSCs and control healthy hiPSCs to form ROs to obtain patient-specific primary cells 
targeted by the disease (i.e., photoreceptors) and explore disease phenotype at the cellular and molecular level. We 
examined the ability of mutation-bearing ROs to generate the entire retinal cell repertoire in correctly laminated 
retinal tissue and explored the advanced structural and molecular features of resultant photoreceptors.
Results
Efficient generation of AIPL1-LCA ROs from patient hiPSCs. Mutations in AIPL1 cause autosomal 
recessive LCA. We employed a previously characterized hiPSC line derived from a LCA patient with a confirmed 
homozygous mutation in AIPL1 (p.Cys89Arg)29 to differentiate as retinal organoids according to a previously 
published protocol24. We employed two hiPSC clones that behaved indistinctly during the differentiation process. 
Figure 1A depicts a schematic of the retinal differentiation protocol while Fig. 1B,C show phase contrast micro-
graphs taken during various stages of AIPL1-LCA hiPSC differentiation. We also differentiated two control hiPSC 
lines (Control 1 and Control 2) derived from unaffected individuals under the same experimental conditions and 
compared results according to the time in differentiating culture, discovering matched morphological changes as 
demonstrated by light microscopy of Control 1 (Supplementary Fig. S1A). Control 2 exhibited the same morpho-
logical changes throughout the differentiation (not shown).
The retinal neuroepithelium formed following manual dissection of optic vesicle (OV)-like structures after 
4 weeks (W) of differentiation (Fig. 1B, W4 and W4' and Supplementary Fig. S1A, W4) and grew in an apically 
convex manner after that (Fig. 1B, W12, and Supplementary Fig. S1A, W12). The translucent projections, repre-
senting presumptive inner segments (ISs), connecting cilia (CC), and nascent OSs, at the apical edge of the ROs 
started to appear at W20 of differentiation and became abundant by W23 (Fig. 1C and Supplementary Fig. S1A) 
similarly to previous reports31,32. Protrusions grew over the subsequent weeks, reaching up to 50 µm in length by 
W26. Excised OVs formed retinal neuroepithelium with an efficiency of 23.6 ± 1.15% (mean ± SD; N = 3 dif-
ferentiation experiments, n > 200 OVs) for AIPL1-LCA and 23.3 ± 1.52% and 24.3 ± 2.5% (mean ± SD; N = 3 
differentiation experiments, n > 200 OVs) in Control 1 and Control 2, respectively (Supplementary Fig. S1B), as 
judged by light microscopy. These results correlated to histological examinations. The morphology adopted by 
W26 was maintained upon prolonged culture to W33 (data not shown) in all genotypes.
Retinal cell specification occurs in AIPL1-LCA and control ROs. We next explored molecular aspects 
of retinal cell specification in differentiating ROs from the AIPL1-LCA patient hiPSC line and from the two con-
trol hiPSC lines (combined as one control because of similar gene expression profiles as described previously33), 
by analyzing transcriptome profiles at four different time points (day (D) 25, D60, D88, and D123 corresponding 
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to W4, W9, W13, and W18, respectively). These time points span retinal organoid formation before the appear-
ance of apical protrusions from ROs. During development, multipotent retinal progenitor cells (RPC) are com-
mitted to specific lineage (precursors) and eventually give rise to all six neurons of the retina and Müller glia. 
The employed differentiation protocol recapitulates retinal neurogenesis, capturing the transient progenitor and 
precursor states before reaching mature cell features.
The raw principal component analyses (PCA) plot (with all expressed genes) indicated that the axis cap-
tured the highest variation (17.82%) in the whole transcriptome data corresponds to the differentiation stage 
of the organoids (Supplementary Fig. S2A). Also control and patient-derived organoids are clearly separated by 
PC2 (y-axis) (Supplementary Fig. S2A and Fig. S4A). Although PCA showed that AIPL1-LCA samples develop 
slightly faster, this phase shift was negligible as indicated by retinal cell type markers (Fig. 2). This may suggest 
that timing of development was similar for both genotypes. In addition, the high RV (Multivariate extension of 
the Pearson correlation coefficient, called RV coefficient, measures similarity of multiple attributes with multiple 
features in two datasets34) (0.89), the quantitative measure of development time comparison between control and 
AIPL1-LCA transcriptomes, supported this hypothesis (Supplementary Fig. S2B).
Then, we checked the established cell type –specific genes in the retina (Fig. 2). Figure 2A depicts the expres-
sion pattern for RPC markers, which displayed an upregulation in expression of the eye field transcription fac-
tors (PAX6, RAX, SIX3, and LHX2), whereas downregulation of expression was evident for RPC genes that are 
selectively repressed in developing retinas (ATOH7, ASCL1, and NEUROG2). We next explored retina-specific 
transcription factors and their co-regulators; Fig. 2, panel B shows the early activation of the orthodenticle home-
obox 2 (OTX2) photoreceptor precursor cell marker and its downstream target CRX, which is upregulated during 
photoreceptor development. We observed the expression of NR2E3 and its transcriptional activator NRL (neural 
leucine zipper) together with their interacting protein PIAS3 according to the correct transcriptional hierarchy 
of rod differentiation. Furthermore, we noted the later activation of nuclear hormone receptors, such as retinoic 
acid receptor-related orphan receptor alpha (RORA), another regulator of retinal development and function. The 
expression of transcription factors required for development, survival, and specification of cone photoreceptors 
also increased over time (e.g., cone thyroid hormone receptor B (THRB), associated with cone viability, or RXRG, 
an S-OPSIN suppressor known to be active in immature cones).
We observed the upregulation of other photoreceptor-specific proteins such as AIPL1 and RECOVERIN 
by W9 (D60) of differentiation and before NRL expression both in control and AIPL1-LCA ROs, in accord-
ance with previous observations in human retinas21,35 (Fig. 2C). No change was evident in AIPL1 expression 
in both developmental schemes, and the single nucleotide missense mutation did not affect alignment qual-
ity and quantity (Figs. 2C,D). The expression of mature rod and cone cell markers such as G-protein-coupled 
Figure 1. Generation of 3D AIPL1-LCA ROs from Patient hiPSCs. (A) Schematic of the differentiation 
protocol. (B) Phase contrast micrographs of differentiation stages: hiPSCs, floating aggregates of hiPSCs 
following treatment with dispase (W2), and aggregates plated on growth factor reduced (GFR) Matrigel-coated 
plates reach a typical morphology by week 4 (W4) are dissected manually and are grown in suspension after 
that (W4’). The typical transparent neuroepithelial domain (*) is formed (W12) with stratified appearance. 
Inset at larger magnification is shown (W12'). At W20 the projections at the surface begin to emerge (inset, 
arrowhead). Scale bars: 200 µm. (C) By week 23 (W23) the ROs reached 1–1.5 mm in diameter and displayed 
dense translucent projections at the apical edge (black arrowhead) that grow after that (W26). The double arrow 
shows the presumptive ONL. Abbreviations: 3D, three-dimensional; RO, retinal organoids; GFR, growth factor 
reduced; W, week; Tau, taurine; RA, retinoic acid; FBS, fetal bovine serum; ULA, ultra-low attachment plates; 
ONL, outer nuclear layer.
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receptor RHODOPSIN increased at W18, while we failed to detect cone-specific OPN1MW by W18 (D128) 
of differentiation (Figs. 2C,D). We observed low levels of OPN1SW expression. We also detected the activation 
of phototransduction proteins both in rods (PDE6B, PDE6G, PDE6A, GUCA1A, GUCA1B, and CNGB1) and 
cones (PDE6C, CNGB3, GNAT2, and GNB3) in a similar fashion in control and AIPL1-LCA ROs. The pres-
ence of other retinal cell type-specific markers suggested the genesis of horizontal (PROX1), bipolar, amacrine 
(NEUROD1, NEUROD4) and ganglion cell types (transient expression of POU4F1, POU4F2, ISL1, or increasing 
expression of THY1) in all ROs (Fig. 2E–I).
The only exception to the overall similarity in expression profiles between the control and AIPL1-LCA ROs 
was in NEUROD6 (Fig. 2G), a helix-loop-helix transcription factor involved in GABAergic amacrine cell subtype 
specification36. We failed to observe NEUROD6 expression in AIPL1-LCA ROs.
Taken together, these data suggest the activation of the molecular networks required for retinal cell specifi-
cation, which follows the chronological cell birth sequence of the native retina for both healthy and AIPL1-LCA 
ROs.
Differential expression (DE) analyses between the time points, within each group separately, revealed 
at least 2-fold levels of alterations in 3794 genes, with 2182 genes common between groups (Supplementary 
Fig. S3A). 797 genes and 815 genes showed response to time either in control or patient derived ROs respec-
tively (Supplementary Fig. S3A). The gene ontology (GO) terms of intersecting genes (Supplementary Fig. S3B) 
reflect a summary of GO terms belonging to clusters having a similar developmental pattern in both datasets 
(Supplementary Fig. S3C,D). GO identified enrichment in genes associated with mitotic cell division, signal 
release from the synapse, and visual perception suggesting that the main steps of commitment toward ret-
inal cell fates occur in both genotypes. The number of DE genes with respect to time unique to each group 
Figure 2. Heatmaps illustrate gene expression profiles of retinal progenitor cells (RPC), retinal transcription 
factors (TF), and retinal cell type-specific genes at distinct organoid stages from RNA-seq data at day (D) 25, 60, 
88, and 123 (corresponding to weeks 4, 9, 13, and 18, respectively) of differentiation. RNA-Seq data show that 
most genes exhibited comparable expression pattern between control and AIPL1-LCA ROs at respective stages. 
Different colors represent the expression value as log2 transformed CPM values. Expression of each gene is 
represented as their average across samples N = 3–5 differentiation experiments with n = 15–20 ROs each. Blue 
to red represents low to high gene expression.
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indicated differences between both development schemes even though the core development is very compa-
rable. The genes unique to the control group (797) are enriched in neuronal connection-formation related GO 
terms (Supplementary Fig. S3B). AIPL1-LCA mutant-specific genes belonged to two GO terms; one related to 
antigen possession for immune responses, and the other related to microtubule functioning (Supplementary 
Fig. S3B). The transcriptomic differences between the two groups could be used to direct appropriate downstream 
experiments.
Moreover, clustering of all the time-responsive DE genes revealed 12 clusters, (C1-C12), with some differences 
between the two groups (Supplementary Fig. S3C). Four clusters showed gene expression changes that are likely 
caused by AIPL1 mutation in patient organoids. C1 genes are turned off earlier in the control, whereas their 
down regulation during maturation is slower in the patient-derived retinal organoid samples. Genes in C7 exhibit 
increasing expression with time in the patient organoids but not appreciably in controls. Expression of C8 genes 
peaks at D88 in the control group; however, their expression continues to be high at D123 in the patient group. 
C9 genes are showing increasing expression with developmental time in control group, but not in the patient 
organoids.
Although the differences in gene expression profiles had no apparent effect on normal differentiation of retina, 
especially on the formation of the OS, DE genes unique to either group showed substantial disruption on time 
matching compared to common DE genes indicated by RV coefficients 0.69 and 0.95, respectively (Supplementary 
Fig. S4B,C). Furthermore, the captured meaningful variation (related to the developmental time) by PCA of com-
mon DE genes was not much higher than that of all expressed genes (less than 9%, 26.69%, and 17.82%, respec-
tively) (Supplementary Fig. S2A and S4A).
We also studied the differentiation progress of AIPL1-LCA hiPSCs by immunofluorescence. We examined 
the genesis of retinal cell types by following the expression of a panel of major retinal cell type markers spanning 
the 27 weeks of differentiation (Supplementary Fig. S5). hiPSC-derived ROs followed the temporal sequence of 
expression of human retinal cells24, namely ganglion cells followed by photoreceptor progenitors, amacrine, and 
horizontal cell types. Towards the end of the differentiation process, photoreceptors mature and are then followed 
by the appearance of bipolar cells  and Müller glia. We detected ganglion cells by NEUN staining at W9, followed 
by the OTX2 and CRX early photoreceptor progenitor markers, which were restricted toward the presumptive 
outer nuclear layer (ONL) on the apical border at later stages. We detected the expression of NRL, the earliest 
rod-specific marker, at W13 in 33,3 ± 5% of the ROs (16 ROs analyzed, n = 3 differentiation experiments). The 
AP2 pan amacrine cell marker began to be expressed before W10, while CALRETININ positive immunostain-
ing, specific for the type II subtype, appeared later at W13. We observed the CALBINDIN horizontal cell marker 
basally at W13 followed by an increase in the number of cells and the segregation to the presumptive intermediate 
layer. We also observed fluorescence signal at the apical surface of the ROs, which we presume to be cones, as 
CALBINDIN can also label cone cells37,38. Müller glia exhibited a weak cellular retinaldehyde-binding protein 
(CRALBP) staining by W17 but high expression at W21, with the characteristic extended feet across the organoid. 
The bipolar cells were born last and were not detected until W25 (not shown).
Overall, the time course of retinal cell genesis in the absence of functional AIPL1 followed the conserved 
sequence of emergence of vertebrate retinal cells, with ganglion cells being born first, followed by photore-
ceptor precursors, horizontal, amacrine, and later by Müller glia, bipolar cells, and maturing photoreceptors. We 
observed the organization of retinal cell types along the apico-basal axis in agreement with their distribution in 
the native retina.
AIPL1-LCA ROs exhibit correctly-organized ONL and support synaptic contact formation. We 
next explored the ultrastructure of ROs derived from AIPL1-LCA hiPSCs and compared them to control ROs 
using transmission electron microscope (Fig. 3 and Supplementary Fig. S6). Analysis of the apical surface of 
ROs at W27 revealed an ONL-like layer with distinguishable cone-like cells with large cell bodies and clear large 
nuclei lying adjacent to the apical border (Fig. 3A). We detected dark nuclei pertaining to presumptive rods in 
several stratified layers deeper in the ONL-like layer (Fig. 3A). We also observed protruding mitochondria-rich 
ISs, reminiscent of the mature ellipsoid in the native retina, at the apical edge (Fig. 3A’). The ISs presented CC and 
basal body (BB) with the typical microtubule organization parallel to the CC axes and juxtaposed centriole (Ce) 
(Fig. 3B). Occasionally, the CC protrude into vesicles with membranous structures, the precursors of the disc 
stacks reminiscent of organelle-free OSs (Fig. 3C). Typically, the rudimentary OSs could not be traced to their 
CC and ISs probably due to the small CC diameter which is not captured in fine microscopic sections (Fig. 3D). 
The examination of the retinal organoid sections revealed photoreceptor synaptic ribbons, the structural special-
ization of ribbon synapses, in the area below the dark presumably rod nuclei (Fig. 3A, inset). The synaptic ribbon 
could be distinguished as an electron dark bar with docked presynaptic vesicles lying orthogonally to the presyn-
aptic membrane (Fig. 3E-E’). The presence of a single bar is characteristic of rod spherules, while cone pedicles 
exhibited multiple circularly arranged bars tethering toward the same presynaptic membrane (not shown).
Overall, the ultrastructural examination revealed similar mature features found in AIPL1-LCA and control 
ROs of the same differentiation stage (Supplementary Fig. S6), also showing similarities to previous reports31,32.
Photoreceptors in AIPL1-LCA ROs express mature photoreceptor markers. To test whether the 
mutation in AIPL1 affects the expression of major mature photoreceptor markers, we examined a large number 
of photoreceptor-specific proteins for their levels of expression and subcellular distributions by immunofluores-
cence in AIPL1-LCA ROs. Figure 4 establishes the apical expression of all photoreceptor-specific proteins in the 
presumptive ONL layer at W27 of differentiation. We detected RECOVERIN apically, staining the entire retinal 
organoid apical border, and in isolated cells at the outer edge of the inner nuclear layer (INL), presumably staining 
bipolar cells. We first detected RHODOPSIN, a selective marker for rods, at W21 of differentiation in restricted 
regions in AIPL1-LCA and control ROs (not shown). During later stages of differentiation, RHODOPSIN showed 
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Figure 3. Representative Electron Micrographs of AIPL1-LCA ROs. (A) Ultrastructure of the ONL-like region: 
ISs protruding at the apical side of the organoid, cone-like cells (C) at the outermost side of the ONL with large 
cell body and large bright nucleus and cytoplasmic mitochondria (white arrow). Deeper aligned, presumably 
rod photoreceptors with electron dark nuclei (r). White square showing the area where synaptic ribbons 
identified. (A’) Higher magnification of ISs (black arrowheads) at the apical border with elongated mitochondria 
(white arrowheads) and OLM (white arrows). (B) Longitudinal section of CC (white arrow) arising from the 
ISs with the BB at the base and the Ce at a right angle below the BB. The transversal section of the CC reflecting 
microtubules arranged to form a cylinder (black arrow). (C) CC protrudes into organelle-free vesicle with 
membranous structure precursors of the disc stacks (white arrowhead) of the OSs. (D) CC arising from the 
IS and a transversal section of the CC lying in the area outward of the IS (white arrows). Dark cross-striation 
representing rootlet filaments (black arrowheads, Ro) protruding from the BB toward the cytoplasm. Organelle 
free vesicles, presumably presenting nascent OSs (black arrows), observed in the vicinity of the CC outward of 
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positive staining along the apical edge with characteristic membrane staining revealing a typical elongated rod cell 
body (arrow) localized deep in the ONL-like layer, and accumulation in ISs (arrowhead). L/M OPSIN positively 
stained cone cells with larger stubby cell bodies (arrow) adjacent to the presumptive outer limiting membrane 
(OLM) and ISs protruding outward (arrowhead). We rarely observed S OPSIN in patient and control samples, 
and in both cases, any staining was localized to individual cells at the apical edge of the organoid. We occasionally 
observed positively stained cells deeper in the organoid, reflecting cells that have not yet reached their final allo-
cation (arrowhead). We detected rod ARRESTIN expression in rod-like cells aligned to the presumptive ONL-like 
layer. Rod ARRESTIN staining revealed a typically segmented rod with ISs (arrowhead) protruding beyond a 
presumptive OLM and deeply localized elongated cell body (arrow). ARRESTIN 3, a pan cone marker, stained 
larger ISs (arrowhead) and cone cell bodies (arrow) at the apical edge of both AIPL1-LCA and control retinal 
organoid sections and cells localized below the presumptive ONL, presumably cones that have not yet reached 
the apical location.
To investigate the development of cilia, we stained for the ARL13B ciliary marker in both ROs, observing 
staining at the apical surface. The rod-specific TRANSDUCIN-α subunit and RetGC (not shown) phototransduc-
tion proteins were also expressed in the presumptive ONL-like layer positively staining the ISs and less intensely 
the cell bodies (inset).
Thus, we did not detect any significant differences with regards to the expression of photoreceptor-specific 
markers and their localization between AIPL1-LCA and control ROs.
Lower expression levels of AIPL1 and PDE6α in AIPL1-LCA ROs. We finally employed immuno-
fluorescence to examine AIPL1 expression at different stages during the differentiation protocol for control and 
AIPL1-LCA ROs. Figure 5A demonstrates the early expression of AIPL1 at W9 in the control sample, as faint 
staining at the apical-most part of the organoid. At W13, the ROs exhibited disperse staining across the neu-
roepithelium. AIPL1 positive cells accumulated at the apical side by W21, showing cytoplasmatic staining of ISs 
(arrowheads), soma (arrow), and axons as described in native retina39. We observed more prominent staining 
by W27 at which point we observed that the entire organoid was lined by AIPL1 positive staining at the apical 
border.
In contrast, AIPL1-LCA ROs displayed only weak staining at W21 and W27 under the same experimental 
conditions. The AIPL1 signal was significantly reduced between patient and Control 1 ROs at W27 (Fig. 5B). 
We verified the expression of AIPL1 by immunoblotting, and in line with immunofluorescence data, we found 
a dramatic reduction in expression of AIPL1 in patient-derived ROs as compared with control ROs collected at 
W27 of differentiation (Supplementary Fig. S7A) and in W33-old ROs (Fig. 5D and Supplementary Fig. S7B).
Animal models had shown that AIPL1 deficiency causes destabilization of PDE6 by preventing its assembly, 
which leads to rapid protein degradation8. In the native retina, PDE6 complex is synthesized and assembled in 
the cytosol of photoreceptor IS, and subsequently traffics to the OS, the site of phototransduction cascade40. We 
performed immunofluorescence to detect PDE6α in ROs and detected positive staining in a portion of control 
ROs (26,6 ± 5,7% N = 17 ROs, n = 3 differentiation experiments) in the ISs. None of the AIPL1-LCA ROs dis-
played PDE6α signal at the apical surface at the same differentiation stage (Fig. 5C). We corroborated the reduced 
levels of PDE6α by immunoblotting W27 and W33 ROs (Supplementary Fig. S7A and Fig. 5D). We also assayed 
for PDE6 heteromer assembly using a previously characterized monoclonal antibody, ROS-1, that recognizes a 
fully assembled PDE6 complex. Our pull-down with ROS-1 in both AIPL1-LCA and control ROs revealed the 
presence of assembled PDE6 (Fig. 5E and Supplementary Fig. S7C).
Thus, in line with the AIPL1 animal model data8,14,41, we observed reduced levels of the AIPL1 primary target 
protein PDE6α, in AIPL1-LCA RO photoreceptors. Of note, the reduction in AIPL1 and PDE6α protein levels 
were not caused by a reduction in their mRNA levels (Supplementary Fig. S8).
Therefore, AIPL1-LCA ROs exhibited a reduction in the levels of AIPL1 protein and decreased PDE6α expres-
sion, whereas other examined photoreceptor markers remained unaltered. Altogether, our findings show that 
despite reduced levels of AIPL1 and PDE6, the assembly of PDE6 heteromer is not affected in AIPL1-LCA ROs.
Discussion
In this study, we set out to identify the early events in the development of LCA4 and understand disease pathol-
ogy in the patient’s genetic background. Previous studies described AIPL1 expression early in development, at 
fetal week 11.8 in central human retina39, at the fetal age of 59 days, concurrent with the expression of OTX221 
and NRL, a master regulator of rod photoreceptor differentiation35. Given the early expression of AIPL1 during 
development and the early clinical onset of AIPL1-caused vision loss, we rationalized the recapitulation of retino-
genesis in a retinal organoid model as the most appropriate means to study disease-related events.
We provide evidence that AIPL1-LCA ROs exhibit a similar morphology to that of healthy control ROs during 
differentiation. Specifically, AIPL1-LCA ROs exhibit a similar efficiency in neuroepithelium formation with the 
concomitant appearance of apical protrusions during W20 of culture that reaches up to 50 µm in length in both 
genotypes by W26. The concurrent differentiation dynamics were also evidenced by gene expression analysis that 
supported temporally-matched profiles for AIPL1-LCA and control ROs. Transcriptional dynamics during reti-
nal differentiation were similar between the two genotypes, as indicated by the RV coefficient of 0.89 and this gen-
erally agreed with what we currently understand about mammalian retinal development, such as the hierarchical 
ISs. (E,E’). Multiple synaptic ribbons with electron dense bars (white arrowheads) surrounded by presynaptic 
vesicles (white arrows). Abbreviations: ONL, outer nuclear layer; ISs, inner segments; OLM, outer limiting 
membrane; CC, connecting cilium; BB, basal body; Ce, centriole; Ro, rootlets; OS, outer segment.
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activation of photoreceptor precursor markers (OTX, CRX, RECOVERIN) or rod and cone-specific markers 
(NRL, NR2E3, GNGT1, PDE6H, GNGT2, GNAT2)21,42,43. AIPL1-LCA ROs formed main retinal cell types (pho-
toreceptors, bipolar, ganglion, amacrine, horizontal cells, and Müller glia) ordered in a correctly stratified native 
retina-like manner with photoreceptors aligning to the presumptive ONL, apical-most distributed cones, and 
deeper allocated rods in several layers. Horizontal and amacrine cells migrated toward their corresponding loca-
tion in the presumptive INL, while the ganglion cell layer was confined to the basal edge. Müller glia spanned 
the entire neuroepithelia with characteristic feet extending beyond the photoreceptor somata to the OLM. We 
observed synaptic contacts in the presumptive outer plexus underneath the dark rod nuclei with typical retinal 
ribbon synapse ultrastructure. Moreover, the ultrastructural features of photoreceptors, such as the formation 
of ISs, cilia and developing OSs, were similar to the control ROs. Pan photoreceptor and cone- and rod-specific 
marker immunoreactivity did not show significant differences in expression pattern.
We observed differences between AIPL1-LCA and control ROs with regards to immunoreactivity to AIPL1, 
with lower staining in the patient hiPSC-derived ROs compared to control ROs. The reduction in levels of AIPL1 
Figure 4. Immunofluorescence staining for mature photoreceptor cell markers in cryosections of AIPL1-
LCA and Control ROs after 27 weeks of differentiation. Immunohistochemistry of RECOVERIN (dotted line 
indicates the gap between the ONL and INL, inset showing low magnification image), OPSIN L/M, OPSIN S 
(S), Rod ARRESTIN (rARRESTIN, inset shows lower magnification image), ARRESTIN 3 (inset shows lower 
magnification image). Arrowheads indicate ISs and arrows indicate photoreceptor cell bodies. ARL13B is a 
connecting cilia marker. Inset showing higher magnification of labeled cilia (arrowheads). α-TRANSDUCIN 
labels rod photoreceptor cells. Inset showing higher magnification of stained cells. Arrowheads indicate OLM 
narrowing beyond the ISs. Nuclei were counterstained with DAPI (blue). RECOVERIN and RHODOPSIN 
panels show DAPI staining at the left and right half, respectively. All data labelled as Control are from Control 
1 ROs; Control 2 behaved indistinctly. Abbreviations: RO, retinal organoids; ISs, inner segments; OLM, outer 
limiting membrane, INL, inner nuclear layer; ONL, outer nuclear layer.
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p.Cys89Arg is likely due to misfolding of AIPL1 and consequent degradation. This finding contrasts with the 
exogenously overexpressed AIPL1 p.Cys89Arg and other missense mutants whose expression was similar to 
wild-type AIPL1 in HEK293T and COS-7 cells9,19. We hypothesize that this difference in mutant AIPL1 stabil-
ity can be attributed to the heterologous expression system under the exogenous, strong promoter that evades 
endoplasmic reticulum surveillance or that photoreceptors employ more stringent quality control systems. This 
finding highlights the importance of studying protein fate in the physiologically relevant cellular environment.
In keeping with the known role for AIPL1 in regulating the levels and assembly of PDE6, our study demon-
strated a reduction in PDE6α levels in AIPL1-LCA ROs. mRNA expression levels for AIPL1 and PDE6α 
remained unaltered in AIPL1 Cys89Arg genotype, corroborating the findings in mouse models and suggesting 
that AIPL1 acts post-translationally on PDE6α.
Despite the associated clinical phenotype being characterized by early-onset severe visual loss in patients bear-
ing the AIPL1 c.256 T > C mutation, we were unable to detect overt photoreceptor degeneration in this model. 
We also failed to observe reactive gliosis, as assessed by GFAP expression, and increased cell death, as assessed by 
apoptotic markers, in AIPL1-LCA ROs (data not shown). The ultrastructural examinations failed to detect early 
Figure 5. AIPL1 and PDE6α Expression in Control and AIPL1-LCA ROs. (A) Immunohistochemistry of 
AIPL1 at W9, W13, W21, and W27 in Control and AIPL1-LCA ROs. AIPL1 can be detected as early as W9 
of differentiation in control ROs; AIPL1 shows scattered staining across the NR at W13. At W21 and W27 
AIPL1 + cells align apically in the ONL-like region. Weak staining in the ONL-like region can be appreciated 
at week 21 and 27 in AIPL1-LCA ROs. The right half of the images show nuclei counterstained with DAPI 
(blue). (B) AIPL1 relative fluorescence intensity in control and AIPL1-LCA ROs at W27 cryosections (mean 
± SD, n = 16 ROs from N = 3 differentiation experiments each, Unpaired student t test, ***P < 0.001). (C) 
Immunohistochemistry of PDE6α in Control and AIPL1-LCA ROs at W27 of differentiation. Nuclei were 
counterstained with DAPI (blue). (D) Western blotting of AIPL1 (MW 43 kDa), RECOVERIN (MW 26 kDa) 
and PDE6α (MW 99 kDa) expression in W33-old patient and Control 1 ROs. (E) Immunoprecipitation with 
ROS-1 antibody (IP) and immunoblotting with PDE6α (IB). PDE6α expression shown in T (total protein in the 
ROs lysate), U (Unbound fraction), E (Elution). Full blot images shown in Supplementary Fig. S7B and S7C. All 
data labelled as Control are from Control 1 ROs. Abbreviations: RO, retinal organoid; ONL, outer nuclear layer; 
NR, neural retina; W, week.
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signs of photoreceptor degeneration, such as shorter ISs, OSs, nuclear disorganization or IS vacuolar inclusions as 
observed in animal models8. These observations can be attributed to several concurring events.
First, the ROs support photoreceptor maturation up to the formation of nascent OSs. The ultrastructural 
examination showed OS-like vesicles with membranous formations inside, reminiscent of stacked membrane 
disks both in AIPL1-LCA and control RO photoreceptors after 27 weeks in culture. We did not observe further 
maturation after that, including OS elongation or membranous discs stack formation. PDE6α, the primary AIPL1 
interacting protein, localized to photoreceptor ISs probably due to incomplete formation of OSs, where it resides 
in mature photoreceptors. Such rudimentary OSs formation has been observed in native rods in fovea at fetal 
week 2644, matching the temporal stage in this in vitro model. Therefore, the phototransduction machinery has 
not been activated yet with consequently unaltered cGMP levels, the main trigger of photoreceptor cell death. 
Despite many efforts, the incomplete formation of OSs in this retinal organoid model has yet to be overcome, 
either by prolonged cell culture or through direct contact with an RPE layer.
Second, high-resolution optical coherence tomography in the foveal region in young LCA4 patients suggests 
that the outer retina may be preserved in patients up to one year of age45. These observations are in concordance 
with the proposed “biochemical dysplasia” category of LCA, described by Koenekoop et al., since patients‘ retinal 
outer and inner layer appear intact in the presence of defective AIPL1, in contrast to “aplasia” and “degeneration” 
subtypes of the disease46.
This first human LCA4 model identifies the reduction of AIPL1 levels as the earliest disease event while ROs 
preserve inner and outer retinal morphology at least until the stage of OS formation. This finding excludes the 
hypothesis that AIPL1 is necessary for rod and cone development and supports the notion that AIPL1 func-
tion is linked to phototransduction activity in photoreceptors. The generation of patient-specific diseased tis-
sue via hiPSCs allows for the generation of human disease models without genetic manipulation and represents 
an unprecedented resource to study clinically relevant phenotypes and cell therapy approaches. So far, hiPSC 
LCA models have addressed the deficiency in ciliary protein CEP290 required for ciliogenesis and ciliary traffic 
control, the structural component that could be followed by fluorescent labeling or ultrastructural exploration. 
The present study addresses the modeling of phototransduction protein defects whose phenotype may be fully 
captured by further maturation of photoreceptors and functional analyses including light exposure to initiate the 
visual cascade.
This model underscores the features captured by model animals, i.e., lower levels of AIPL1 and PDEα, as well 
as aspects that require additional consideration to phenocopy the disease fully. The particularly suitable short size 
of the AIPL1 gene supports gene therapy approaches47–49, and this personalized model could present an excellent 
resource in which to test different optimization strategies. Fine tuning of adeno-associated virus transfer vector 
design or dosing tests will be necessary to improve therapeutic gene expression in human photoreceptors, and 
this approach represents a unique clinically relevant resource.
Materials and Methods
hiPSC lines, cell culture and retinal differentiation. The cell lines employed in this study include the 
hiPSC cell line (LCA-FiPS4F1)29 from the LCA patient homozygous for the mutation in AIPL1, p.Cys89Arg 
(c.265 T > C) and two control hiPSC cell lines: Ctrl2-FiPS5F2 (Control 1)50 and Ctrl1-FiPS4F1 (Control 2), were 
subjected to the same differentiation conditions in parallel. All cell lines are deposited in the Spanish National 
Stem Cell Bank (www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/).
hiPSCs were cultured in plates coated with BD MatrigelTM, human embryonic stem cell-qualified Basement 
Membrane Matrix (Corning) using mTeSR1 medium. Passages were performed using Dispase (STEMCELL 
Technologies, #07913), every 5–7 days at 1:6–1:10 split ratio. Quality controls such as mycoplasma contamina-
tion, karyotype verification, and cell line authentication were regularly performed.
The hiPSC lines were induced to differentiate toward 3D neural retina following the protocol published by 
Zhong et al.24. The hiPSC were grown to 60–80% confluency and then lifted with dispase or EDTA, pipetted up 
and down and transferred to ultra low attachment (ULA) plates for 1 week in neural-induction medium (NIM) 
(DMEM/F12 (1:1), 1x N2 supplement (Invitrogen), 1X MEM non-essential amino acids (NEAA), 2 µg/ml hepa-
rin (Sigma)). The floating aggregates were then transferred to plates coated with BD, MatrigelTM-Growth Factor 
Reduced (GFR) (Corning) and left to grow for 2 weeks. The OV-like structures were excised with the needle and 
cultured individually in ULA 96 well plates in neural retina medium (NRM, DMEM:DMEM/F12 (2:1), 1x B27 
(Invitrogen), 1X NEAA, and 1% antibiotic–antimycotic). At day 42 of culture, the NRM was supplemented with 
10% FBS (Gibco), Taurine (100 µM), all-trans retinoic acid (1 µM). From day 93 the retinoic acid was reduced to 
0,5 µM.
Immunohistochemistry. hiPSC-ROs were fixed in PFA 4% for 30 min at room temperature (RT). 
Thereafter the ROs were introduced into 10%, 20% and 30% sucrose successively O/N at 4 °C and included into 
OCT. Histological sections, 10 µm thick, were performed using Microm HM 505E cryostat. Antibodies used are 
described in Supplementary table S1. DAPI (40,6-diamidino-2-phenylindole) was used for nuclear counterstain-
ing. Slides were mounted with Vectashield (Vector Laboratories). The images were taken on Leica SP8 confocal 
microscope with HC PL APO CS2 63×/1.40 OIL and HC PL APO CS2 40×/1.30 OIL objectives and processed by 
Leica LAS AF, Photoshop CS2 (Adobe), and Image J software. All presented images labelled as Control are from 
Control 1. No differences in retinal cell type expression and distribution were observed between Control 1 and 
Control 2.
Transmission electron microscopy. hiPSC-ROs were fixed in 4% paraformaldehyde, 2,5% glutaraldehyde 
in 0.1 M sodium phosphate buffer (pH 7,2–7,4) for 1,5 h and washed with the same buffer. Then, the samples 
were post-fixed with 2% osmium, rinsed, dehydrated and embedded in Durcupan resin (Fluka, Sigma-Aldrich, 
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St. Louis, USA). Serial semi-thin sections (1.5 µm) were cut with an ultramicrotome Ultracut UC-6 (Leica, 
Heidelberg, Germany), mounted onto slides and stained with 1% toluidine blue in 1% Borax and analyzed under 
a light microscope. Ultrathin sections (0.07–0.09 µm) were prepared with the Ultracut and stained with lead 
citrate. Finally, photomicrographs were obtained under a transmission electron microscope FEI Tecnai G2 Spirit 
(FEI Europe, Eindhoven, Netherlands) using a digital camera Morada (Olympus Soft Image Solutions GmbH, 
Münster, Germany). Sample processing was performed by CIPF Electron Microscopy Core Facility.
Western blot and Immunoprecipitation (IP). Control 1, Control 2 and AIPL1-LCA ROs collected at 
W27 (N = 2) and Control 1 and AIPL1-LCA ROs collected at W33 (N = 2) were lysed in RIPA buffer (R0278 
Sigma) containing a protease inhibitor coctail (Roche), and total protein was quantified using a Bradford Reagent 
protein assay (B6916 Sigma-Aldrich). Protein lysates were denatured by 1X SDS Sample Buffer. The resulting 
samples were incubated at 95 °C for 5 min. Protein samples (20–30 µg) were then separated on TGX Stain-FreeTM 
Gels (BioRad), and electroblotted onto a PVDF membrane (Trans-Blot® TurboTM Transfer Pack/ Bio-Rad). 
Membranes were cut horizontally (at ladder bands corresponding to MW 72 kDa, and 34 kDa) into 3 strips, 
incubated in blocking buffer (5% nonfat dried milk diluted in TBS + 0,1% Tween) for 1 h at room temperature, 
washed three times in TBS + 0.1% Tween for 5 min and each strip incubated with corresponding primary anti-
body (AIPL1, 1:10.000, RECOVERIN 1:1000 and PDE6α 1:1000) in blocking buffer overnight at 4 °C. Thereafter, 
blots were washed three times in TBS + 0.1% Tween and incubated with secondary HRP-conjugated antibody in 
blocking buffer for 45 min at RT. Blots were washed another five times and protein bands were visualized using 
SuperSignal West Pico PLUS (Thermo Scientific) on X-ray films (AIPL1, RECOVERIN, PDE6α) and G.BOX 
Chemi XX6 (SYNGENE) system (PDE6α).
To analyze effect of AIPL1 C89R mutation on PDE6 complex assembly, immunoprecipitation (IP) was per-
formed with antibody against ROS-1. This was followed by immunoblotting (IB) with PDE6α antibody. 25 Weeks 
retinal organoids derived from controls and AIPL1-LCA patient were lysed in 200 µl of lysis buffer (50 mM Tris.
Cl-pH 7.4, 300 Mm NaCl, 5 Mm EDTA and 0.02% Sodium Azide) containing Protease inhibitor pellet, 10 mM of 
iodoacetamide and 1% triton X-100. After centrifugation at the speed of 14000 × g for 30 sec at 4 °C; the super-
natant (T) was incubated with 5 µg of antibody (ROS-1) for 2 h at 4 °C followed by incubation with 10 µl of A/G 
agarose beads for 3 h at 4 °C. The Unbound proteins (U) were removed by centrifugation at 14000 × g for 30 sec at 
4 °C. The beads were washed three times with 1 ml of the wash buffer (0.1% triton x-100, 50 mM Tris.Cl-pH 7.4, 
300 Mm NaCl, 5 Mm EDTA and 0.02% Sodium Azide) and a final wash in 1 ml of 1 × PBS. After the wash, the 
samples were eluted to a final concentration of 1X SDS sample buffer (4x Tris-Cl/SDS pH6.8, 30% glycerol, 10% 
SDS, 0.6 M DTT and 0.012% bromophenol and β-mercaptoethanol). The samples were boiled for 5 min. 10 µL of 
each sample were loaded on SDS PAGE gel and then immunoblotted using PDE6α antibody diluted in 1:1 ratio of 
blocking buffer (Licor) and 1X PBST (1:1000). The blot was imaged using Li-cor imaging system. This experiment 
was repeated three times with different retinal organoids samples each time.
Ethical approval. The study was approved by the corresponding Ethics Committee CAEC (Comité Etico 
Autonomico de Estudios Clínicos), Valencia, Spain. Informed consent was signed by the involved human sub-
jects. All procedures were done in accordance with institutional guidelines and regulations.
Data availability
All raw and processed data are available through Gene Expression Omnibus GSE131877 (www.ncbi.nlm.nih.
gov/GEO).
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